Lorazepam 65219-0368-02
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- December 13, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA217598
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lorazepam | 2 mg/mL |
Drug Class
Benzodiazepine [EPC]Benzodiazepine [EPC]Benzodiazepines [CS]
Packaging Options(1)
25 VIAL in 1 TRAY (65219-368-24) / 1 mL in 1 VIAL (65219-368-14)